About Us
Asia Air WatchLive PM2.5 Medical Alerts
Research Watch
•स्क्रिनमा देखिने चुरोट: सुर्तीजन्य हानि न्यूनीकरण नीतिमा दक्षिण एसियाले अझै के छुटाइरहेको छ•नेपालमा पिसाब नलीको संक्रमण र एन्टिबायोटिक प्रतिरोधको बढ्दो संकट•Frontline Perspectives on Nursing Leadership in Nepal•Protecting the Smallest Lungs from the Hidden Grip of RSV in Kathmandu•The Heavy Burden of Bullying on Student Wellbeing in Nepal•The Emerging Landscape of Thyroid Health in Central Nepal•How a Recent Western Nepal Study is Redefining Anemia Diagnosis•How H. Pylori is Impacting the Health of Karnali’s High-Altitude Communities•Sweet Poison, Bitter Reality: The Unseen Diabetes Epidemic Among Nepal’s Youth•How Missing Checklists and Protocols are Costing Lives in Nepal’s ERs•स्क्रिनमा देखिने चुरोट: सुर्तीजन्य हानि न्यूनीकरण नीतिमा दक्षिण एसियाले अझै के छुटाइरहेको छ•नेपालमा पिसाब नलीको संक्रमण र एन्टिबायोटिक प्रतिरोधको बढ्दो संकट•Frontline Perspectives on Nursing Leadership in Nepal•Protecting the Smallest Lungs from the Hidden Grip of RSV in Kathmandu•The Heavy Burden of Bullying on Student Wellbeing in Nepal•The Emerging Landscape of Thyroid Health in Central Nepal•How a Recent Western Nepal Study is Redefining Anemia Diagnosis•How H. Pylori is Impacting the Health of Karnali’s High-Altitude Communities•Sweet Poison, Bitter Reality: The Unseen Diabetes Epidemic Among Nepal’s Youth•How Missing Checklists and Protocols are Costing Lives in Nepal’s ERs

UDP-glucuronosyltransferases in hepatic metabolism and hepatocellular carcinoma: Current status and future perspectives on subcellular localization.

Researchers

Hye In Ka, Hee Doo Yang, Hyun Sun Jung, Hyung Seok Kim, Jung Woo Eun

Abstract

UDP-glucuronosyltransferases (UGTs) are essential phase II metabolic enzymes that catalyze the glucuronidation of both xenobiotics and critical endogenous metabolites, including bilirubin, bile acids, steroid hormones, and bioactive lipid mediators, thereby maintaining systemic and hepatic metabolic homeostasis. Dysregulated UGT expression and impaired glucuronidation capacity are widely documented in liver diseases and hepatocellular carcinoma (HCC). Beyond canonical endoplasmic reticulum (ER) localization, accumulating biochemical and immunological evidence suggests that selected UGT isoforms may also reside in noncanonical membrane-associated compartments, such as the nuclear envelope and plasma membrane, under specific cellular contexts. In this review, we comprehensively summarize the genomic architecture, isoform-specific functional diversification, and molecular regulation of the human UGT superfamily, while presenting updated quantitative kinetics for major endogenous substrates. We further critically evaluate the experimental evidence for canonical and extra-ER UGT localization, addressing fundamental topological constraints, cofactor (UDP-glucuronic acid) transport, and organelle-specific catalytic feasibility. Finally, we synthesize current quantitative transcriptomic, proteomic, and functional findings on UGT dysregulation in HCC, while delineating established clinical observations from hypothetical models regarding whether organellar redistribution influences cancer-associated metabolic reprogramming. Overall, this review provides a balanced, evidence-based synthesis of UGT spatial biology and outlines decisive research avenues for clarifying the role of compartmentalized glucuronidation in hepatic health and malignancy.
Source: PubMed (PMID: 43035055)View Original on PubMed